drugset / Trial / NCT07163572
Comparison of Intravenous Brivaracetam Versus Levetiracetam in the Management of Status Epilepticus
RandomizedParallel-groupOpen-labelTreatment
Summary
Brivaracetam is increasingly being studied in adult status epilepticus populations, evidence in pediatric patients remains sparse, with only limited case series and observational studies reporting favorable outcomes. This study aims at direct comparison between intravenous brivaracetam and levetiracetam in the acute management of pediatric status epilepticus.
Timeline
- Start
- 2025-01-16
- Primary completion
- 2025-08-16
- Completion
- 2025-08-16
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Brivaracetam | Small molecule | 2 mg/kg | Intravenous |
| Subject | Levetiracetam | Other / unclassified | 40 mg/kg | Intravenous |
Indications
No indication recorded.